153 related articles for article (PubMed ID: 12924452)
1. Vesicant characteristics of oxaliplatin following antecubital extravasation.
Kennedy JG; Donahue JP; Hoang B; Boland PJ
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):237-9. PubMed ID: 12924452
[TBL] [Abstract][Full Text] [Related]
2. Extravasation of oxaliplatin: an infrequent and irritant toxicity.
Pericay C; López A; Soler JR; Bonfill T; Dotor E; Saigí E
Clin Transl Oncol; 2009 Feb; 11(2):114-6. PubMed ID: 19211378
[TBL] [Abstract][Full Text] [Related]
3. A midline for oxaliplatin infusion: the myth of safety devices.
Masters B; Hickish T; Cidon EU
BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24903726
[TBL] [Abstract][Full Text] [Related]
4. A case report of oxaliplatin extravasation.
Foo KF; Michael M; Toner G; Zalcberg J
Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
[No Abstract] [Full Text] [Related]
5. Management of extravasation of oxaliplatin.
de Lemos ML; Walisser S
J Oncol Pharm Pract; 2005 Dec; 11(4):159-62. PubMed ID: 16595069
[TBL] [Abstract][Full Text] [Related]
6. [Reversible tissue damage after paravasal infusion of oxaliplatin].
Boesen C; Nielsen SE
Ugeskr Laeger; 2015 Jan; 177(4):V07140390. PubMed ID: 25613210
[TBL] [Abstract][Full Text] [Related]
7. Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy.
Haslik W; Hacker S; Felberbauer FX; Thallinger C; Bartsch R; Kornauth C; Deutschmann C; Mader RM
Eur J Surg Oncol; 2015 Mar; 41(3):378-85. PubMed ID: 25515823
[TBL] [Abstract][Full Text] [Related]
8. Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration.
To YY; Sutcliffe KJ; Hoen HM; Swaney RA; Nicholls JD; Crocenzi TS
J Oncol Pharm Pract; 2016 Apr; 22(2):256-60. PubMed ID: 25762052
[TBL] [Abstract][Full Text] [Related]
9. Extravasations of oxaliplatin.
Kretzschmar A; Pink D; Thuss-Patience P; Dörken B; Reichert P; Eckert R
J Clin Oncol; 2003 Nov; 21(21):4068-9. PubMed ID: 14581435
[No Abstract] [Full Text] [Related]
10. Acute ototoxicity from a single infusion of oxaliplatin.
Malhotra NK; Aslam R; Lipman SP; Bilski VJ
Ear Nose Throat J; 2010 Jun; 89(6):258-61. PubMed ID: 20556736
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin hypersensitivity: case report and successful repeat desensitization.
Edmondson DA; Gruling BJ; Urmanski AM; Wong SJ; Levy MB
Am J Ther; 2007; 14(1):116-8. PubMed ID: 17303980
[TBL] [Abstract][Full Text] [Related]
12. Vesicant extravasation part II: Evidence-based management and continuing controversies.
Wickham R; Engelking C; Sauerland C; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1143-50. PubMed ID: 17149397
[TBL] [Abstract][Full Text] [Related]
13. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
[TBL] [Abstract][Full Text] [Related]
14. Preventing and managing vesicant chemotherapy extravasations.
Schulmeister L
J Support Oncol; 2010; 8(5):212-5. PubMed ID: 21086879
[TBL] [Abstract][Full Text] [Related]
15. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
Nozawa H; Muto Y; Yamada Y
Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
[TBL] [Abstract][Full Text] [Related]
16. Anaphylactic reaction to oxaliplatin: a case report.
Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
[No Abstract] [Full Text] [Related]
17. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.
Baker DE
Rev Gastroenterol Disord; 2003; 3(1):31-8. PubMed ID: 12684591
[TBL] [Abstract][Full Text] [Related]
18. [Readministration of oxaliplatin using a rapid desensitization method after severe anaphylactic reaction].
Arotçarena R; Berthélémy P; Piot M; Pariente A
Gastroenterol Clin Biol; 2001 Feb; 25(2):206-7. PubMed ID: 11319450
[No Abstract] [Full Text] [Related]
19. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
[TBL] [Abstract][Full Text] [Related]
20. Extravasation of chemotherapeutic agents.
Hankin FM; Louis DS
Am Fam Physician; 1985 Mar; 31(3):147-50. PubMed ID: 3976457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
